In summary, our study is the first to report that HMOX1 negatively regulates MMP-9 expression in CLL cells in response to ATO, through modulation of the p38 MAPK/AP-1 signaling pathway. This evidence concerns the gene MMP9 and B-cell chronic lymphocytic leukemia.